40 active
/
226 total (since 2015)
7
Phase 1 Active
47 total
16
Phase 2 Active
76 total
14
Phase 3 Active
72 total
10
Phase 4 Active
51 total
Top Sponsors (Industry)
Sorted by active Active Done Failed
Sanofi 2 1 0
AbbVie 2 0 0
Galderma R&D 1 13 0
Sun Pharmaceutical Industries Limited 1 6 0
Zhejiang Sunshine Mandi Pharmaceutical Co.,Ltd. 1 1 0
Shanghai Huaota Biopharmaceutical Co., Ltd. 1 0 0
Sagimet Biosciences Inc. 1 0 0
Jiangxi Kvvit Pharmaceutical Co., Ltd. 1 0 0
Biofrontera Inc. 1 0 0
Eurofarma Laboratorios S.A. 1 0 0
Equipmed USA LLC 1 0 0
Bausch Health Americas, Inc. 0 15 0
Sun Pharmaceutical Industries, Inc. 0 10 0
Novan, Inc. 0 5 0
Vyne Therapeutics Inc. 0 5 0
NCT07384208 RECRUITING
A Study to Assess Efficacy and Safety of N-Acetyl-GED-0507-34-LEVO Gel 5% in Patients With Acne Vulgaris (GEDACNE 2)
PPM Services S.A. n=400
NCT07384195 RECRUITING
A Study to Assess Efficacy and Safety of N-Acetyl-GED-0507-34-LEVO Gel 5%, in Patients With Acne Vulgaris (GEDACNE-1)
PPM Services S.A. n=400
NCT07389109 RECRUITING
A Long-term Safety and Efficacy Study of N-Acetyl-GED-0507-34-LEVO Gel 5%, in Subjects With Acne Vulgaris (GEDACNE-LT)
PPM Services S.A. n=400
NCT07207369 RECRUITING
A Study to Assess the Safety and Effectiveness of ELAPR002f Injectable Gel in Adult Participants With Atrophic Acne Scars
AbbVie n=395
NCT07186413 RECRUITING
A Study to Compare the Efficacy, Safety and Pharmacokinetics of Trifarotene 50 mcg/g Cream in Chinese Subjects With Acne Vulgaris
Galderma R&D n=561
NCT06787222 ACTIVE NOT RECRUITING
Effectiveness and Safety of Zingiber Officinale Transdermal Patch for Acne Vulgaris; Study of Interleukin 1 and Skin Microbiome
Hasanuddin University n=26
NCT06403501 RECRUITING
Efficacy and Safety of Clascoterone Cream 1% in Facial Acne Vulgaris
Zhejiang Sunshine Mandi Pharmaceutical Co.,Ltd. n=692
NCT05995340 ACTIVE NOT RECRUITING
ELAPR002f Injectable Gel in the Treatment of Atrophic Acne Scars
AbbVie n=157
NCT04028401 RECRUITING
Optimization of Skin Preparation to Reduce Cutibacterium Acnes Colonization in Superficial and Deep Samples During Prosthetic Shoulder Surgery in Male Patients
Nantes University Hospital n=110
NCT06905210 NOT YET RECRUITING
Study of New Antiandrogenic Progestogen + Low-dose Estrogen for Moderate Acne Vulgaris
Eurofarma Laboratorios S.A. n=526
NCT06447480 RECRUITING
Clinical Trial to Compare Oral Isotretinoin to Standard of Care in Moderate Acne Skin of Color Patients
Centre Hospitalier Universitaire de Nice n=420
NCT06775314 NOT YET RECRUITING
The Effectiveness and Safety of Cleanser Containing Triethyl Citrate, Pyruvic Acid, Combination Cream Containing Triethyl Citrate, Ethyl Linoleate, GT Peptide-10, Salicylic Acid 0,5%, Zinc Lactate, Hyaluronic Acid and Spot Cream Containing Triethyl Citrate, Ethyl Linoleate, GT Peptide-10, Honokiol
Dr.dr.Irma Bernadette, SpKK (K) n=102
NCT06602284 NOT YET RECRUITING
A Full Face Study to Evaluate the Efficacy of Dermapen 4™ Microneedling Device in Addition with MG-CLR Serum for Acne Treatment Over 12 Weeks.
Equipmed USA LLC n=10
NCT06340984 NOT YET RECRUITING
Serum Intercellular Adhesion Molecule -1 in Acne Vulgaris Patients : Effect of Montelukast
South Valley University n=60
NCT06248008 COMPLETED
A Study to Evaluate Safety of ASC40 Tablets in Patients With Moderate to Severe Acne Vulgaris
Ascletis Pharmaceuticals Co., Ltd. n=240
NCT05608499 TERMINATED
Duobrii Treatment of Acne Keloidalis Nuchae (AKN)
Icahn School of Medicine at Mount Sinai n=15
NCT06090721 COMPLETED
DMT310-009 Topical in the Treatment of Acne Vulgaris
Dermata Therapeutics n=520
NCT06192264 COMPLETED
A Study to Evaluate the Safety and Efficacy of ASC40 (Denifanstat) Tablets in the Treatment of Patients With Moderate to Severe Acne Vulgaris
Ascletis Pharmaceuticals Co., Ltd. n=480
NCT06242288 COMPLETED
Correlation Between Depression Scores and Serum NF-ĸB/NLRP3 Axis, Biotinidase, and HMGB After Treatment With Isotretinoin in Patients With Acne Vulgaris
Mostafa Bahaa n=40
NCT05550337 COMPLETED
Study Comparing Trifarotene Cream, 0.005% To AKLIEF ® (Trifarotene 0.005% Cream) In The Treatment Of Acne Vulgaris
Teva Pharmaceuticals USA n=807
NCT06451237 COMPLETED
Acne Remission Maintenance by Weekend Systemic Isotretinoin
Alexandria University n=60
NCT04214639 COMPLETED
Clinical Study Comparing the Efficacy and Safety of IDP-126 Gel in the Treatment of Acne Vulgaris
Bausch Health Americas, Inc. n=183
NCT04214652 COMPLETED
Clinical Study Comparing the Efficacy and Safety of IDP-126 Gel in the Treatment of Acne Vulgaris
Bausch Health Americas, Inc. n=180
NCT04960930 COMPLETED
To Evaluate the Efficacy and Safety of Minocycline Hydrochloride Foam in the Treatment of Moderate-to-severe Acne Vulgaris
Cutia Therapeutics (Shanghai) Co., Ltd n=372
NCT02667444 COMPLETED
P3 Study Comparing Once Daily SB204 and Vehicle Gel in Acne
Novan, Inc. n=1,330
NCT03334682 COMPLETED
Randomized Double-blind Study on the Benefit of Spironolactone for Treating Acne of Adult Woman.
Nantes University Hospital n=158
NCT03664739 COMPLETED
Study Comparing the Safety and Efficacy of IDP-120 Gel and IDP-120 Vehicle Gel in the Treatment of Acne Vulgaris
Bausch Health Americas, Inc. n=608
NCT03664752 COMPLETED
Study Comparing the Safety and Efficacy of IDP-120 Gel and IDP-120 Vehicle Gel in the Treatment of Acne Vulgaris
Bausch Health Americas, Inc. n=585
NCT05629468 COMPLETED
Comparing Efficacy of Azithromycin and Probiotics for Treatment of Acne Vulgaris
Pak Emirates Military Hospital n=75
NCT05573425 COMPLETED
Comparing the Efficacy of Topical Tazarotene Gel 0.1% v/s Microneedling in Atrophic Post Acne Scars
Jinnah Postgraduate Medical Centre n=202
NCT02832063 COMPLETED
Clinical Trial in Subjects With Mild to Moderate Acne Vulgaris
AOBiome LLC n=372
NCT02815280 COMPLETED
A Study to Compare the Efficacy and Safety of Topical Administration of FMX-101 for Treatment of Moderate-to-Severe Acne
Vyne Therapeutics Inc. n=495
NCT02815267 COMPLETED
A Study to Compare the Efficacy and Safety of Topical Administration of FMX-101 for Treatment of Moderate-to-Severe Acne
Vyne Therapeutics Inc. n=466
NCT03271021 COMPLETED
A Study to Evaluate the Efficacy and Safety of Topical Administration of FMX101 in the Treatment of Moderate-to-Severe Acne Vulgaris
Vyne Therapeutics Inc. n=1,488
NCT03761810 COMPLETED
A Study of S6G5T3 in the Treatment of Acne Vulgaris
Sol-Gel Technologies, Ltd. n=434
NCT03761784 COMPLETED
A Study of S6G5T-3 in the Treatment of Acne Vulgaris
Sol-Gel Technologies, Ltd. n=424
NCT03915860 COMPLETED
Participant Reported Outcomes With Use of Trifarotene 50 μg/g Cream in the Treatment of Moderate Facial and Truncal Acne Vulgaris
Galderma R&D n=47
NCT02515305 COMPLETED
Comparative Safety and Efficacy of Two Treatments in the Treatment of Acne Vulgaris
Padagis LLC n=890
NCT03393494 COMPLETED
Bioequivalence Study of Two Treatments in the Treatment of Acne Vulgaris on the Face
Padagis LLC n=825
NCT03028363 COMPLETED
A Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris
Dermira, Inc. n=759
NCT03073486 COMPLETED
A Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris
Dermira, Inc. n=744
NCT03127956 COMPLETED
A Long-term Safety Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris
Dermira, Inc. n=748
NCT03717506 COMPLETED
Bioequivalence Study of Clindamycin Phosphate Topical Lotion, 1% in Subjects With Acne Vulgaris
Balmoral Medical company n=1,236
NCT03168321 COMPLETED
A Phase 3, Vehicle-controlled Efficacy and Safety Study of IDP-123 Lotion in the Treatment of Acne Vulgaris (301)
Bausch Health Americas, Inc. n=813
NCT03168334 COMPLETED
A Phase 3, Vehicle-controlled Efficacy and Safety Study of IDP-123 Lotion in the Treatment of Acne Vulgaris (302)
Bausch Health Americas, Inc. n=801
NCT03290027 COMPLETED
A Study of the Safety and Efficacy of DFD-03 for the Treatment of Acne Vulgaris
Dr. Reddy's Laboratories Limited n=550
NCT03292640 COMPLETED
A Study of the Safety and Efficacy of DFD-03 Lotion in the Treatment of Acne Vulgaris for 12 Weeks
Dr. Reddy's Laboratories Limited n=547
NCT02932267 COMPLETED
Subject Reported Outcomes With Use of Adapalene 0.3% - Benzoyl Peroxide (BPO) 2.5% in Dark Skin Acne
Galderma R&D n=50
NCT02608450 COMPLETED
A Study to Evaluate the Safety and Efficacy of CB-03-01 Cream, 1% in Subjects With Facial Acne Vulgaris (25)
Cassiopea SpA n=708
NCT02608476 COMPLETED
A Study to Evaluate the Safety and Efficacy of CB-03-01 Cream, 1% in Subjects With Facial Acne Vulgaris (26)
Cassiopea SpA n=732
NCT02682264 COMPLETED
An Open-Label, Long-Term Extension Study to Evaluate the Safety of CB-03-01 Cream, 1% in Participants With Acne Vulgaris
Cassiopea SpA n=609
NCT03522441 COMPLETED
Bioequivalence Study of Clindamycin Gel 1% in Treatment of Acne Vulgaris
Akorn, Inc. n=1,125
NCT04329403 WITHDRAWN
Clinical Endpoint Bioequivalence Study of Adapalene Gel 0.1%
Aurobindo Pharma Ltd
NCT02651220 COMPLETED
Clinical End Point Study of Generic Adapalene and Benzoyl Peroxide Gel Versus Epiduo® Forte Gel in Treatment of Acne Vulgaris
Actavis Inc. n=1,001
NCT02616614 COMPLETED
Double-blind Placebo-controlled Trial of Generic Clindamycin/Benzoyl Peroxide Gel Versus Onexton Gel in Acne Vulgaris
Actavis Inc. n=862
NCT03615768 COMPLETED
A Study to Evaluate the Efficacy and Safety of Adapalene-Clindamycin Combination Gel in the Treatment of Acne Vulgaris
Lee's Pharmaceutical Limited n=1,617
NCT04015375 COMPLETED
Study Comparing Test to Aczone 7.5% and Both to a Placebo Control in the Treatment of Acne Vulgaris
Torrent Pharmaceuticals Limited n=1,150
NCT02932306 COMPLETED
Efficacy and Safety of IDP-121 and IDP-121 Vehicle Lotion in the Treatment of Acne Vulgaris
Bausch Health Americas, Inc. n=820
NCT02965456 COMPLETED
Efficacy and Safety of IDP-121 and IDP-121 Vehicle Lotion in the Treatment of Acne Vulgaris
Bausch Health Americas, Inc. n=820
NCT02189629 COMPLETED
CD5789 (Trifarotene) Long Term Safety Study on Acne Vulgaris
Galderma R&D n=453
NCT02566369 COMPLETED
Efficacy and Safety of CD5789 (Trifarotene) 50μg/g Cream Versus Vehicle Cream in Acne Vulgaris
Galderma R&D n=1,208
NCT02556788 COMPLETED
Double-Blind Efficacy and Safety of CD5789 (Trifarotene) 50µg/g Cream Versus Vehicle Cream in Acne Vulgaris
Galderma R&D n=1,212
NCT03650361 COMPLETED
Bioequivalence Study of Adapalene Gel 0.3% in Subjects With Facial Acne Vulgaris
Aleor Dermaceuticals Limited n=755
NCT03178994 COMPLETED
The Study of Efficacy and Safety of 2% Ketoconazole Cream in Thai Females With Mild Degree of Post - Adolescence Acne
Chulalongkorn University n=42
NCT02413346 COMPLETED
A Multi-Center Open-Label Evaluation of the Safety of Sarecycline Tablets in the Treatment of Acne Vulgaris
Almirall, S.A. n=490
NCT02886715 COMPLETED
A Study Comparing Tazarotene Cream 0.1% to TAZORAC® (Tazarotene) Cream 0.1% and Both to a Placebo Control in the Treatment of Acne Vulgaris
Fougera Pharmaceuticals Inc. n=1,110
NCT02465632 COMPLETED
To Study Generic Clindamycin 1%/Benzoyl Peroxide 5% Topical Gel (Glenmark Generics, Ltd) in the Treatment of Acne Vulgaris.
Glenmark Pharmaceuticals Ltd. India n=1,100
NCT03071549 COMPLETED
Combined Salicylic and Azaleic Acid Verus Trichloroacetic Acid 25% Peel in Treatment of Acne
Cairo University n=34
NCT02865005 COMPLETED
Trial of Dapsone 5.0% Gel in the Treatment of Acne Vulgaris
Seegpharm S.A. n=2,361
Data: ClinicalTrials.gov